The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes

Microbiology

Volumn 158, Issue 4, 2012, Pages 869-876

  Sanders, Holly ^a   Brehony, Carina ^b   Maiden, Martin C J ^b   Vipond, Caroline ^a   Feavers, Ian M ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; FHBP GENE; GENETIC TRANSCRIPTION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION REGULATION, BACTERIAL; IRON; NEISSERIA MENINGITIDIS; TRANSCRIPTION, GENETIC;

NEISSERIA MENINGITIDIS;

EID: 84859123481     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.054957-0     Document Type: Article

References (35)

1. Abe, H. & Aiba, H. (1996). Differential contributions of two elements of rho-independent terminator to transcription termination and mRNA stabilization. Biochimie 78, 1035-1042.
2. Ambur, O. H., Frye, S. A. & Tønjum, T. (2007). New functional identity for the DNA uptake sequence in transformation and its presence in transcriptional terminators. J Bacteriol 189, 2077-2085.
3. Bartolini, E., Frigimelica, E., Giovinazzi, S., Galli, G., Shaik, Y., Genco, C., Welsch, J. A., Granoff, D. M., Grandi, G. & Grifantini, R. (2006). Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection. Mol Microbiol 60, 963-972.
4. Borrow, R., Carlone, G. M., Rosenstein, N., Blake, M., Feavers, I., Martin, D., Zollinger, W., Robbins, J., Aaberge, I. & other authors (2006). Neisseria meningitidis group B correlates of protection and assay standardization-international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine 24, 5093-5107.
5. Bullen, J. J., Spalding, P. B., Ward, C. G. & Rogers, H. J. (1992). The role of Eh, pH and iron in the bactericidal power of human plasma. FEMS Microbiol Lett 94, 47-52.
6. Cantini, F., Savino, S., Scarselli, M., Masignani, V., Pizza, M., Romagnoli, G., Swennen, E., Veggi, D., Banci, L. & Rappuoli, R. (2006). Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis. J Biol Chem 281, 7220-7227.
7. Crack, J., Green, J. & Thomson, A. J. (2004). Mechanism of oxygen sensing by the bacterial transcription factor fumarate-nitrate reduction (FNR). J Biol Chem 279, 9278-9286.
8. Didelot, X., Urwin, R., Maiden, M. C. J. & Falush, D. (2009). Genealogical typing of Neisseria meningitidis. Microbiology 155, 3176-3186.
9. Donnelly, J., Medini, D., Boccadifuoco, G., Biolchi, A., Ward, J., Frasch, C., Moxon, E. R., Stella, M., Comanducci, M. & other authors (2010). Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci U S A 107, 19490-19495.
10. Edwards, J., Cole, L. J., Green, J. B., Thomson, M. J., Wood, A. J., Whittingham, J. L. & Moir, J. W. B. (2010). Binding to DNA protects Neisseria meningitidis fumarate and nitrate reductase regulator (FNR) from oxygen. J Biol Chem 285, 1105-1112.
11. Feavers, I. M. (2000). Bacterial genomics: ABC of meningococcal diversity. Nature 404, 451-452.
12. Findlow, J., Borrow, R., Snape, M. D., Dawson, T., Holland, A., John, T. M., Evans, A., Telford, K.-L., Ypma, E. & other authors (2010). Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin Infect Dis 51, 1127-1137.
13. Genco, C. A. & Desai, P. J. (1996). Iron acquisition in the pathogenic Neisseria. Trends Microbiol 4, 179-184.
14. Giuliani, M. M., Biolchi, A., Serruto, D., Ferlicca, F., Vienken, K., Oster, P., Rappuoli, R., Pizza, M. & Donnelly, J. (2010). Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus. Vaccine 28, 5023-5030.
15. Grifantini, R., Sebastian, S., Frigimelica, E., Draghi, M., Bartolini, E., Muzzi, A., Rappuoli, R., Grandi, G. & Genco, C. A. (2003). Identification of iron-activated and-repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B. Proc Natl Acad Sci U S A 100, 9542-9547.
16. Halperin, S. A., Gupta, A., Jeanfreau, R., Klein, N., Reisinger, K., Walter, E., McCarthy, M., Karsten, A., Bedell, L. & other authors (2010). Clinical Immunogenicity and Safety Profile of Two Quadrivalent Meningococcal Conjugate Vaccines in 2907 2-to-10-year-old Children. Presented at 17th International Pathogenic Neisseria Conference, 11-16 September, 2010, Banff, AB, Canada.
17. Jacobsson, S., Hedberg, S. T., Mölling, P., Unemo, M., Comanducci, M., Rappuoli, R. & Olcén, P. (2009). Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine 27, 1579-1584.
18. Jiang, H. Q., Hoiseth, S. K., Harris, S. L., McNeil, L. K., Zhu, D. Z., Tan, C. W., Scott, A. A., Alexander, K., Mason, K. & other authors (2010). Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28, 6086-6093.
19. Jolley, K. A. & Maiden, M. C. J. (2010). BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11, 595.
20. Jolley, K. A., Brehony, C. & Maiden, M. C. J. (2007). Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev 31, 89-96.
21. Kingsford, C. L., Ayanbule, K. & Salzberg, S. L. (2007). Rapid, accurate, computational discovery of Rho-independent transcription terminators illuminates their relationship to DNA uptake. Genome Biol 8, R22.
22. Koeberling, O., Delany, I. & Granoff, D. M. (2011). A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines. Clin Vaccine Immunol 18, 736-742.
23. Madico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M. & Ram, S. (2006). The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177, 501-510.
24. Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J. J., Zurth, K. & other authors (1998). Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95, 3140-3145.
25. Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Arico, B., Brunelli, B., Pieri, A., Santini, L. & other authors (2003). Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 197, 789-799.
26. Maslanka, S. E., Gheesling, L. L., Libutti, D. E., Donaldson, K. B. J., Harakeh, H. S., Dykes, J. K., Arhin, F. F., Devi, S. J. N., Frasch, C. E. & other authors (1997). Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin Diagn Lab Immunol 4, 156-167.
27. Oriente, F., Scarlato, V. & Delany, I. (2010). Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter. J Bacteriol 192, 691-701.
28. Perkins-Balding, D., Ratliff-Griffin, M. & Stojiljkovic, I. (2004). Iron transport systems in Neisseria meningitidis. Microbiol Mol Biol Rev 68, 154-171.
29. Rappuoli, R. (2010). Meningococcal Biology and Vaccines: ten Years of Genomics and Reverse Vaccinology. Presented at 17th International Pathogenic Neisseria Conference, 11-16 September, 2010, Banff, AB, Canada.
30. Seib, K. L., Serruto, D., Oriente, F., Delany, I., Adu-Bobie, J., Veggi, D., Aricò, B., Rappuoli, R. & Pizza, M. (2009). Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. Infect Immun 77, 292-299.
31. Seib, K. L., Oriente, F., Adu-Bobie, J., Montanari, P., Ferlicca, F., Giuliani, M. M., Rappuoli, R., Pizza, M. & Delany, I. (2010). Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection. Vaccine 28, 2416-2427.
32. Seib, K. L., Brunelli, B., Brogioni, B., Palumbo, E., Bambini, S., Muzzi, A., DiMarcello, F., Marchi, S., van der Ende, A. & other authors (2011). Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun 79, 970-981.
33. Snape, M. D. & Pollard, A. J. (2005). Meningococcal polysaccharideprotein conjugate vaccines. Lancet Infect Dis 5, 21-30.
34. Welsch, J. A., Ram, S., Koeberling, O. & Granoff, D. M. (2008). Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. J Infect Dis 197, 1053-1061.
35. Yongye, A. B., Gonzalez-Outeiriño, J., Glushka, J., Schultheis, V. & Woods, R. J. (2008). The conformational properties of methyl a-(2,8)-di/trisialosides and their N-acyl analogues: implications for anti-Neisseria meningitidis B vaccine design. Biochemistry 47, 12493-12514.